secwatch / observer
8-K filed May 17, 2023, 7:59 PM ET ticker SRXH CIK 0001471727
leadership confidence high sentiment neutral materiality 0.70

Better Choice names Kent Cunningham as CEO; Conacher steps down as interim CEO

SRx Health Solutions, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Lionel F. Conacher

Interim Chief Executive Officer
SRXH · SRx Health Solutions, Inc.
Effective
2023-05-22
Successor
Kent Cunningham
Filed
May 17, 2023, 7:59 PM ET
Lionel F. Conacher, age 60, will resign from his role as Interim Chief Executive Officer of the Company, effective May 22, 2023.
Appointed

Kent Cunningham

Chief Executive Officer
SRXH · SRx Health Solutions, Inc.
Effective
2023-05-22
Filed
May 17, 2023, 7:59 PM ET
On May 11, 2023, the Company announced that Kent Cunningham, age 52, was appointed as Chief Executive Officer of the Company, effective May 22, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lionel F. Conacher resigned as Interim Chief Executive Officer at SRx Health Solutions, Inc..

Action
resigned
Role
Interim Chief Executive Officer
Exact text from the filing
Lionel F. Conacher, age 60, will resign from his role as Interim Chief Executive Officer of the Company, effective May 22, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kent Cunningham was appointed as Chief Executive Officer at SRx Health Solutions, Inc..

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
On May 11, 2023, the Company announced that Kent Cunningham, age 52, was appointed as Chief Executive Officer of the Company, effective May 22, 2023.
View on SEC.gov

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR
accession 0001628280-23-018514
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.